Ecological Co-construction and Win-win Cooperation: China Ocular Health Industrial Park Alliance Conference and International Intelligent Medical-Engineering Innovation Center Achievements Report Held in Changping

Jan 13, 2026 11:25 CST Updated 11:25

TowardPi

High-end Ophthalmic Medical Device Developer

Source of the article: Eye Future

Reprint Requirements: Can be reprinted 24 hours after the first publication.Source required.Source

January 10,China Eye Health Industry Park Alliance Conference and International Intelligent Medical Engineering Innovation Center Achievements Report MeetingHosted at the Innovation and High-Quality Development Exchange Center for China's High-End Medical Equipment in Changping District. Wang Ruichao, member of the Party Leadership Group and Deputy Director of the Beijing Municipal Medical Security Bureau, Qu Jia, Director of the National Clinical Research Center for Ophthalmology and Otolaryngology Diseases and Chairman of the China Eye Valley, and Liu Xiaodong, Deputy Secretary of the Party Committee and District Mayor of Changping District, as well as Deputy Secretary of the Party Working Committee and Director of the Management Committee of Future Science City, attended.

This conference is themed "Ecological Co-construction, Win-Win Cooperation" as the theme, bringing together representatives from key ophthalmology industrial parks across China to jointly initiateEstablish the First Eye Health Industrial Park Alliance in China, Focusing on Collaborative Industrial Park Construction, Open Sharing of Innovative Resources, Efficient Transformation of Scientific Achievements, and Group Overseas Expansion of Key Projects, to carry out in-depth cooperation, build industry consensus, and gather momentum for development.

As one of the "twin-engine" industries driving Beijing's innovative development, pharmaceuticals and healthcare is also one of the leading industries that Changping District has been focusing on for many years. In recent years, Changping District has been committed to building Life Valley with globally leading standards, and has established platforms around sectors such as medical devices, beauty and health, cutting-edge biotechnology, and synthetic biological manufacturing.China's First International Research Hospital, China's First Vaccine Testing Center, and China's First National Medical Device Service Station. A 20 billion yuan investment fund for Beijing's pharmaceutical and health industry has been established, gathering nearly 3,000 pharmaceutical and health companies., a complete industrial chain has been formed from basic research, pilot development, production and circulation to terminal medical care.Industry revenue exceeds 100 billion yuan。

Currently, eye health issues have drawn significant attention, and the eye health industry has become one of the fastest-growing sectors in the pharmaceuticals and healthcare field. In the eye health industry, Changping District, leveraging its strong foundation in pharmaceuticals and healthcare, established the International Intelligent Medical Engineering Innovation Center. This center fosters an integrated development ecosystem encompassing clinical needs, R&D innovation, and industrial transformation. To date, it has attracted...TowardPi, AibornKey enterprises in the industry, such as TowardPi, have introduced heavy-weight products like high-end ophthalmic surgical microscopes and multifocal intraocular lenses.

Taking this conference as an opportunity, Changping District will continue to improve the supporting facilities for the eye health industry, build a collaborative innovation system involving government, industry, academia, research, and medical sectors, and operate the Intelligent Ophthalmology Medical Engineering Industrial Park to high standards. It will promote the cluster development of high-end ophthalmic equipment, eye medicines, and other industries, accelerating the creation of a leading eye health industry cluster in China. At the same time, it will fully support the industry alliance in playing a bridging role, strengthen exchanges and cooperation with other parks, promote resource sharing and complementary advantages, and jointly inject stronger momentum into the innovative development of China's eye health industry.

Participants included the director of the relevant department of Beijing Municipal Science & Technology Commission and Beijing Municipal Drug Administration, member of the standing committee of the district party committee, deputy district mayor, and Liu Qiang, director of the Management Committee of Changping Park, Zhongguan Village Science and Technology Park.

AboutChina Eye Health Industry Park Alliance

China Eye Health Industry Park Alliance

About the International Intelligent Medical Engineering Innovation Center

The Global Medical Engineering Innovation Center (GMEC), jointly guided by the Beijing Tsinghua Industrial Development Research Institute, the China Medical Equipment Association, and the Management Committee of Changping Park, Zhongguancun Science Park, and supported by more than ten enterprises including China Eye Valley and Chang Development Group, is co-organized by TowardPi and the Global Health Industry Innovation Center. The center is located in the International Medical Device City in Changping District — the new global headquarters of TowardPi Medical, and is committed to building an innovative transformation base for intelligent medical equipment led by enterprises, effectively promoting the integration and transformation of industry, academia, research, and medicine, and creating clinical and social value.

About TowardPi Medical

TowardPi was founded in 2017, with its core technology originating from the transformation of scientific and technological achievements at Tsinghua University, and incubated by the Tsinghua Industrial Innovation Research Institute. The core team consists of dozens of teachers and students from various specialties of Tsinghua University, including electronics, biomedical engineering, and precision instruments. The company has built a full product line matrix covering ophthalmic diagnosis and treatment. Core products include ophthalmic OCT, ophthalmic surgical microscopes, ultra-wide-field fundus cameras, and optical biometers, all of which have reached internationally leading performance levels, filling multiple technical gaps in China.

With strong R&D capabilities, TowardPi has achieved several core technology breakthroughs in just a few years, applied for more than a hundred patents domestically and internationally, and its products have been sold to dozens of countries and regions worldwide. In addition, the phacoemulsification and vitrectomy integrated machine, as well as the femtosecond laser cataract products, have entered the late stage of development.

In 2025, TowardPi Medical completed two rounds of financing. In March, the company successfully closed a 500-million-yuan E-round financing, setting a new record for the largest single financing amount in China's ophthalmic equipment sector in the primary market. In September, the company received investment from top state-owned capital Beijing State-owned Capital Operation and Management Center (Beijing Guoguan) and existing shareholder Waterwood Ventures, successfully completing its E+ round of financing. As a leading enterprise in the ophthalmic equipment industry, TowardPi Medical continues to gain high recognition from the capital market.

Statement

Content Declaration:"Eye Future" tracks global medical technology advancements, aiming to disseminate technical and industry knowledge. All content is for professional exchange and academic discussion only, and does not constitute medical advice or commercial promotion. Information regarding companies, products, and registrations mentioned in the text is sourced from publicly available materials or verified channels. If there are any errors or omissions, please contact us for corrections. Email: jacky@suribot.com

Copyright Statement:The original article "Eye Future" is copyrighted by Beijing Siyu Bot Technology Co., Ltd. Without authorization, it shall not be reprinted, excerpted, or mirrored on other websites, WeChat Official Accounts, or commercial platforms. For reprinting, please contact the backend to obtain authorization. This platform reserves the right to pursue legal responsibilities for unauthorized full-text reprinting, content rewriting, or adaptation.